derrierloisirs.fr
» » Metabolic and Molecular Aspects of Cardiomyopathy (Cardiomyopathy Update, 4) (v. 4)

Download Metabolic and Molecular Aspects of Cardiomyopathy (Cardiomyopathy Update, 4) (v. 4) ePub

by Lionel H. Opie,Tsuneaki Sugimoto

Download Metabolic and Molecular Aspects of Cardiomyopathy (Cardiomyopathy Update, 4) (v. 4) ePub
  • ISBN 0860084795
  • ISBN13 978-0860084792
  • Language English
  • Author Lionel H. Opie,Tsuneaki Sugimoto
  • Publisher Univ of Tokyo Pr (December 1, 1991)
  • Pages 250
  • Formats lrf azw lit mbr
  • Category Medicine
  • Subcategory Medicine
  • Size ePub 1645 kb
  • Size Fb2 1477 kb
  • Rating: 4.7
  • Votes: 787

A cardiomyopathy is a heart muscle disease of unknown origin, expressed in a number of disorders such as congestive heart failure, arrhythmias, or sudden death. The fourth volume in the annual series reporting cardiomyopathic research focuses on metabolic, molecular, immunological, and genetic studies. The topics addressed include the molecular biology of cardiac hypertrophy and failure, the intracellular signal transduction system, and clinical studies. Of interest to researchers in cardiology and the disciplines discussed. Annotation copyright Book News, Inc. Portland, Or.

Start by marking Metabolic and Molecular Aspects of Cardiomyopathy (Cardiomyopathy .

Start by marking Metabolic and Molecular Aspects of Cardiomyopathy (Cardiomyopathy Update, 4) (v. 4) as Want to Read: Want to Read savin. ant to Read.

In addition, cardiomyopathies resulting from mitochondrial dysfunction, metabolic abnormalities, storage .

In addition, cardiomyopathies resulting from mitochondrial dysfunction, metabolic abnormalities, storage diseases, and inborn errors of metabolism are described. Non-compaction cardiomyopathy is a relatively rare congenital heart disease characterized by an excessive prominence of trabecular meshwork, and deep recesses of the ventricular myocardium. The most frequent is left ventricular noncompaction (LVNC). LVNC can occur in isolation or coexist with other cardiac and systemic anomalies.

Although the clinical phenotypes of the cardiomyopathies vary, two common features are present in most cardiomyopathy patients: altered Ca(2+) sensitivity of force development and impaired energy metabolism. Here, we present the analyses of how these troponin mutations affect the in vitro contractile protein function and the hypotheses derived to explain the development of these disease states.

PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. 2002 Apr;121(4):1016-9. Assessment of prognosis in idiopathic dilated cardiomyopathy.

Cardiomyopathies are classified according t. .Heritable cardiomyopathies are a class of heart diseases caused by variations in a number of genetic loci. Genetic variants on one allele lead to either a degraded protein, which causes a haploinsufficiency of that protein, or a nonfunctioning protein that subverts the molecular system within which the protein works.

Cardiomyopathy Sudden Cardiac Death Hypertrophic Cardiomyopathy Fabry Disease Sarcomeric Protein. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Journal of molecular and cellular cardiology.

Types of cardiomyopathy include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia, and takotsubo cardiomyopathy (broken heart syndrome). In hypertrophic cardiomyopathy the heart muscle enlarges and thickens. In dilated cardiomyopathy the ventricles enlarge and weaken  . Journal of molecular and cellular cardiology.

Causes of metabolic cardiomyopathy.

This disease can significantly disrupt the habitual lifestyle of a person, and in severe cases - lead to death

This disease can significantly disrupt the habitual lifestyle of a person, and in severe cases - lead to death. Therefore, at the slightest sign of a malfunction of the heart, an urgent need to consult a doctor. 1 Description of metabolic cardiomyopathy. 2 Causes of metabolic cardiomyopathy. 3 Signs of metabolic cardiomyopathy. 4 Diagnosis of metabolic cardiomyopathy. 5 Treatment of metabolic cardiomyopathy. 6 Prevention of metabolic cardiomyopathy. 7 Prognosis for metabolic cardiomyopathy.

However, this distinction is somewhat arbitrary since many of these conditions can be either reversible or nonreversible (eg, ischemic cardiomyopathy). Ischemic cardiomyopathy - Coronary atherosclerosis is the most common cause of heart failure (HF) in the United States, comprising 50 to 75 percent of patients with HF (see "Epidemiology and causes of heart failure").